The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research have drafted five US Food and Drug Administration (FDA) guidance documents focusing on cancer clinical trial eligibility criteria for patients with brain metastases, HIV/AIDS, organ dysfunction, prior and concurrent malignancies and minimum age for enrollment.
